These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 15137175)

  • 1. Activity of cholinesterases in human whole blood measured with acetylthiocholine as substrate and ethopropazine as selective inhibitor of plasma butyrylcholinesterase.
    Reiner E; Bosak A; Simeon-Rudolf V
    Arh Hig Rada Toksikol; 2004 Apr; 55(1):1-4. PubMed ID: 15137175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bambuterol, a carbamate ester prodrug of terbutaline, as inhibitor of cholinesterases in human blood.
    Tunek A; Svensson LA
    Drug Metab Dispos; 1988; 16(5):759-64. PubMed ID: 2906603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of protocols for measuring activities of human blood cholinesterases by the Ellman method.
    Reiner E; Sinko G; Skrinjarić-Spoljar M; Simeon-Rudolf V
    Arh Hig Rada Toksikol; 2000 Mar; 51(1):13-8. PubMed ID: 11059068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of methods used for the determination of cholinesterase activity in whole blood.
    Naik RS; Doctor BP; Saxena A
    Chem Biol Interact; 2008 Sep; 175(1-3):298-302. PubMed ID: 18555980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of cetyltrimethylammonium on the human blood cholinesterases activity].
    Kuznetsova LP; Samokish VA; Sochilina EE
    Ukr Biokhim Zh (1999); 2011; 83(2):29-35. PubMed ID: 21851044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of cholinesterase activity (EC 3.1.1.7; 3.1.1.8) in undiluted plasma and erythrocytes as a tool for measuring in vivo effects of reversible inhibitors.
    Thomsen T; Kewitz H; Pleul O
    J Clin Chem Clin Biochem; 1988 Jul; 26(7):469-75. PubMed ID: 3065439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in active site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase.
    Saxena A; Redman AM; Jiang X; Lockridge O; Doctor BP
    Biochemistry; 1997 Dec; 36(48):14642-51. PubMed ID: 9398183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetylcholinesterase and butyrylcholinesterase activities in obese Beagle dogs before and after weight loss.
    Tvarijonaviciute A; Ceron JJ; Tecles F
    Vet Clin Pathol; 2013 Jun; 42(2):207-11. PubMed ID: 23550593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic model of ethopropazine interaction with horse serum butyrylcholinesterase and its docking into the active site.
    Golicnik M; Sinko G; Simeon-Rudolf V; Grubic Z; Stojan J
    Arch Biochem Biophys; 2002 Feb; 398(1):23-31. PubMed ID: 11811945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhibition by various alkaloids of acetylcholinesterase and butyrylcholinesterase from human blood].
    Kuznetsova LP; Nikol'skaia EB; Sochilina EE; Faddeeva MD
    Zh Evol Biokhim Fiziol; 2002; 38(1):28-31. PubMed ID: 11966199
    [No Abstract]   [Full Text] [Related]  

  • 11. A ratiometric fluorescence probe based on carbon dots for discriminative and highly sensitive detection of acetylcholinesterase and butyrylcholinesterase in human whole blood.
    Xu X; Cen Y; Xu G; Wei F; Shi M; Hu Q
    Biosens Bioelectron; 2019 Apr; 131():232-236. PubMed ID: 30849722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholinesterases exhibiting aryl acylamidase activity in human amniotic fluid.
    Jayanthi LD; Balasubramanian N; Balasubramanian AS
    Clin Chim Acta; 1992 Feb; 205(3):157-66. PubMed ID: 1349516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenyl valerate esterase activity of human butyrylcholinesterase.
    Mangas I; Vilanova E; Estévez J
    Arch Toxicol; 2017 Oct; 91(10):3295-3305. PubMed ID: 28299395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved determination of acetylcholinesterase activity in human whole blood.
    Worek F; Mast U; Kiderlen D; Diepold C; Eyer P
    Clin Chim Acta; 1999 Oct; 288(1-2):73-90. PubMed ID: 10529460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholinesterase reactivation: in vitro studies.
    Ganendran A; Balabaskaran S
    Anaesth Intensive Care; 1975 Feb; 3(1):60-1. PubMed ID: 1130650
    [No Abstract]   [Full Text] [Related]  

  • 16. Rivastigmine is a potent inhibitor of acetyl- and butyrylcholinesterase in Alzheimer's plaques and tangles.
    Eskander MF; Nagykery NG; Leung EY; Khelghati B; Geula C
    Brain Res; 2005 Oct; 1060(1-2):144-52. PubMed ID: 16212945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphism of pseudocholinesterase in Torpedo marmorata tissues: comparative study of the catalytic and molecular properties of this enzyme with acetylcholinesterase.
    Toutant JP; Massoulié J; Bon S
    J Neurochem; 1985 Feb; 44(2):580-92. PubMed ID: 2578181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new approach to determining cholinesterase activities in samples of whole blood.
    Augustinsson KB; Eriksson H; Faijersson Y
    Clin Chim Acta; 1978 Oct; 89(2):239-52. PubMed ID: 709874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibition of cholinesterases by aziridinium derivatives of polymethylene bischloroethylamines].
    Volkova RI; Kochetova LM
    Bioorg Khim; 1983 Jul; 9(7):926-35. PubMed ID: 6679787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Specificity of interaction with acetylcholinesterase and butyrylcholinesterase of choline analogs based on ephedrine and pseudoephedrine].
    Dalimov DN; Vaĭzburg GM; Abdullaeva LK; Abduvakhabov AA; Sadykov AS
    Dokl Akad Nauk SSSR; 1986; 289(1):227-30. PubMed ID: 3732039
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.